INTRODUCTION {#sec1-1}
============

For more than two decades, the prevalence of both obesity and asthma in the developed western populations has been increasing in parallel.\[[@ref1]\] According to data from the American National Health and Nutrition Study (NHANES), the prevalence of obesity increased by 30.5% between 1999 and 2000, and by 37.9% between 2013 and 2014.\[[@ref2]\] Similarly, the number of asthmatic people in America, which was reported to be 14 million in 2001, increased by 33.5% to reach 18.7 million in 2012.\[[@ref3]\]

Such increases in the prevalence of both diseases indicated a potential relationship between the two conditions and led the issue to be investigated in further studies.\[[@ref4][@ref5]\] Although the fundamental factors involved in the relationship between asthma and obesity are still unclear, the factors that have been suggested to play a role include the mechanical pressure of obesity on the lungs, increased inflammatory response within the immune system, and hormonal changes caused by obesity.\[[@ref6][@ref7]\] Not only total body weight or body mass index (BMI) but also body composition and body fat distribution are believed to have certain effects on asthma symptoms.\[[@ref7]\] Studies have shown that a fattening of the thorax along with abdominal obesity decreases asthma control and pulmonary function, particularly in adults.\[[@ref8][@ref9]\]

Changes in lifestyle can also be associated with a rapid increase in the prevalence of asthma. Several diet hypothesis associated with asthma has been suggested in the recent years, and researchers have argued that changes in dietary content have been one of the most important environmental factors increasing the prevalence of asthma.\[[@ref10]\] The transformation of a conventional diet to a modern diet and food processing practices have reduced the total antioxidant amount taken on a diet.\[[@ref11]\] Moreover, it has been suggested that the increasing consumption of fast-food weighted diets has exasperated the symptoms of asthma by increasing the amount of saturated fats taken through the diet.\[[@ref12]\] While inflammatory omega 6 fatty acids are consumed in larger amounts, there has been a decrease in the consumption of anti-inflammatory omega 3 fatty acids, and this increased omega 6/omega 3 ratio resulting from changes in dietary habits has also been suggested as a factor with a negative effect on asthma.\[[@ref10][@ref12]\] That said, the exact effect of any specific macronutrient or micronutrient on asthma is still unclear, and previous studies have reported conflicting results.\[[@ref13][@ref14]\]

Based on the above-mentioned information, the present study aimed to investigate the relationship between obesity and macro--micro nutrient intake as a dietary variable with pulmonary functions and asthma control in adult asthmatics.

METHODS {#sec1-2}
=======

Study population and design {#sec2-1}
---------------------------

This cross-sectional study was carried out in the Pulmonology Department of the Kırsehir Ahi Evran Training and Research Hospital in Turkey. The study included all patients who referred to the clinics over a 2 months\' period in the spring (March 15--May 15, 2017) who were aged between 20 and 65 years, who had been diagnosed with asthma at least 1 year earlier and who agreed voluntarily to take part in the study. In the and, 120 patients were enrolled in the study \[[Figure 1](#F1){ref-type="fig"}\]. The diagnosis of asthma was made by a specialist doctor and documented based on the patient\'s airway hyperresponsiveness history. All patients met the reversibility criteria at the beginning of the study. According to reversibility criteria, test of bronchodilation was performed (using a salbutamol metered dose of 400 mcg) by clinician and reversibility was considered if an increase of at least 12% of FEV~1~ from baseline was achieved.\[[@ref15]\] Pregnant or lactating women were excluded from the study, so as to eliminate the potential effects on body weight and changes in nutritional habits. Patients using systemic corticosteroid medications were also excluded from the study, as these drugs increased food intake and sodium retention.\[[@ref16]\] In addition, patients experiencing asthma exacerbation were also excluded from the study as they were mostly using systemic corticosteroids during these events and experienced a greater than normal decline in pulmonary functions. Before initiating the study, the necessary permissions were obtained from the Kırsehir Ahi Evran Training and Research Hospital, and approval was obtained from the Ankara University Medical Faculty Science Ethics Committee.

![Flowchart of study participants](LI-36-404-g001){#F1}

Anthropometric measurements {#sec2-2}
---------------------------

The body weight measurements of the patients were recorded using a Tanita BC 601 scale in the morning while in a fasted state. Height and waist and hip circumference measurements were obtained using an inflexible measuring tape and according to standard methods (without shoes and wearing thin clothes). All measurements were recorded only once. BMI was calculated by dividing body weight in kilograms by the square of height in meters (kg/m^2^), and the classification was made according to the World Health Organization (WHO) data. Based on their BMI results, the patients were divided into two groups, as normal weight (18.5--24.9 kg/m^2^) and obese (≥30.0 kg/m^2^).\[[@ref17]\] A waist circumference (WC) of 80 cm and above was considered to be indicative of "at risk," while 88 cm and above was considered to indicate "at high risk" in women. A WC of 94 cm and above was considered to be indicative of "at risk," while 102 cm and above was considered to indicate "at high risk" in men. The waist--hip ratio (WHR) was calculated based on the waist and hip circumference measurements and classified according to WHO criteria. A WHR above 0.85 in women and 0.90 in men was considered to be indicative of "at risk."\[[@ref18]\]

Pulmonary function tests {#sec2-3}
------------------------

The pulmonary function test measurements of the patients were obtained by a responsible nurse using a Cosmed Quark Spiro device. Measurements were obtained while the patients were sitting on a flat surface, with measurements repeated three times, and the best mean values considered. Forced expiratory volume in 1 s (FEV~1~), forced vital capacity (FVC), peak expiratory flow (PEF), and mid-expiratory flow (MEF) values were measured. The patients\' age, gender, and height were recorded on the measurement device before the measurements were taken, and the values were evaluated after respiratory maneuvers.\[[@ref19]\]

Asthma control test {#sec2-4}
-------------------

The asthma control test (ACT) consists of five questions that inquire the level of influence of asthma symptoms on daily activities, and each question is scored on a scale of 1--5. The total score that can be obtained from ACT is in a range of 5--25, with a high score indicating better asthma control.\[[@ref20]\] In the present study, ACT was applied to the patients by a specialist physician for the assessment of asthma control.

Assessment of nutrition consumption records {#sec2-5}
-------------------------------------------

The nutrition consumption records of the participants were recorded retrospectively for 1 weekday using the 24-h recall method. A nutrition photograph catalog was used to determine the measures and amounts during recordings.\[[@ref9]\] All consumed nutrients were recorded in detail, and the collected data were evaluated using the Turkey-Specific Nutrition Guide and a computer-supported nutrition program (BeBIS).\[[@ref21]\]

Statistical analysis of data {#sec2-6}
----------------------------

The SPSS (SPSS Statistics for Windows, Version 22.0; IBM Corp, Armonk, NY, USA). software package was used for the evaluation of the data collected in the study. Normally distributed parameters were compared between the two groups using a Student\'s *t*-test, and mean and standard deviation values were presented. A Mann--Whitney *U*-test was used to compare nonnormally distributed parameters between the two groups, and medians and interquartile range (Q1--Q3) values were presented. A Kruskal--Wallis H-test was used to compare more than two nonnormally distributed variables, and a *post hoc* (Tukey) correction was applied to find the source of significant differences. Pearson correlation test was used to evaluate the power and direction of linear relations between two continuous quantitative variables. All statistical analyses were performed within 95.0% confidence interval, and *P* \< 0.05 was considered as statistically significant.

RESULTS {#sec1-3}
=======

The study population consisted of 60 normal weight and 60 obese respondents; the majority of whom were women. The mean age of the normal weight and obese respondents was 39.55 ± 11.0 and 45.1 ± 10.3, respectively. A high proportion of the respondents in the normal weight group were high school graduates (45.0%), while the majority of obese respondents were primary school graduates (60.0%). The majority of the respondents in both groups were living in urban areas and were nonsmokers (≥80.0%). More than half of the respondents had asthma for \>10 years. Of the obese respondents, 38.3% reported increased body weight and 46.7% reported increased appetite after starting on antiasthma medication. These increases were milder in the normal weight respondents when compared to the obese ones. The most common comorbidity was reflux (8.3%) in the normal weight group and diabetes and reflux (11.7%) in the obese group. The mean ACT scores of the obese and normal weight respondents were 17.9 ± 3.7 and 20.6 ± 2.3, respectively. The mean BMI, WC, and WHR of the respondents in the normal weight group were 22.6 ± 1.7 kg/m^2^, 75.5 ± 9.2 cm, and 0.90 ± 0.1, respectively. The mean BMI, WC, and WHR of the obese respondents were 34.6 ± 5.4 kg/m^2^, 96.4 ± 5.6 cm, and 1.4 ± 0.3, respectively \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographic and anthropometric characteristics of the respondents according to body mass index classification

                                                            Normal (*n*=60)   Obese (*n*=60)
  --------------------------------------------------------- ----------------- ----------------
  Age (mean±SD)                                             39.55±11.0        45.1±10.3
  Gender, *n* (%)                                                             
   Male                                                     12 (20.0)         8 (13.3)
   Female                                                   48 (80.0)         52 (86.7)
  Level of education, *n* (%)                                                 
   Primary school graduate                                  22 (36.7)         48 (60.0)
   High school graduate                                     27 (45.0)         9 (35.0)
   University graduate+                                     11 (18.3)         3 (5.0)
  Residential area, *n* (%)                                                   
   Rural                                                    7 (11.7)          12 (20.0)
   Urban                                                    53 (88.3)         48 (80.0)
  Smoking, *n* (%)                                                            
   Nonsmoker/ex-smoker                                      55 (91.7)         54 (90.0)
   Active smoker                                            5 (8.3)           6 (10.0)
  Duration of asthma, *n* (%)                                                 
   1-10 years                                               38 (63.4)         33 (55.0)
   10+ years                                                22 (36.6)         27 (45.0)
  The effect of asthma medication on body weight, *n* (%)                     
   No change                                                40 (66.7)         32 (53.4)
   Increased body weight                                    14 (23.3)         23 (38.3)
   Decreased body weight                                    6 (10.0)          5 (8.3)
  The effect of asthma medication on appetite, *n* (%)                        
   No change                                                38 (63.4)         29 (48.3)
   Increased appetite                                       16 (26.6)         28 (46.7)
   Decreased appetite                                       6 (10.0)          3 (5.0)
  Comorbidities, *n* (%)                                                      
  Diabetes                                                  \-                7 (11.7)
  Hypertension                                              1 (1.7)           4 (6.7)
  Allergic rhinitis                                         3 (5.0)           4 (6.7)
  Reflux                                                    5 (8.3)           7 (11.7)
  ACT score (mean±SD)                                       20.6±2.3          17.9±3.7
  BMI (kg/m^2^) (mean±SD)                                   22.6±1.7          34.6±5.4
  WC (cm) (mean±SD)                                         75.5±9.2          96.4±5.6
  WHR (mean±SD)                                             0.90±0.1          1.4±0.3

Data was presented as, *n* (%) or mean±SD. SD: Standard deviation, ACT: Asthma control test, BMI: Body mass index, WC: Waist circumference, WHR: Waist-hip ratio

The effects of obesity on pulmonary functions {#sec2-7}
---------------------------------------------

When the pulmonary functions of the respondents were compared based on their BMI classification, all parameters other than the PEF value were found to be significantly different between the two groups (*P* \< 0.05). All of the pulmonary function parameters of the respondents with normal BMI values were higher than in the obese respondents \[[Table 2](#T2){ref-type="table"}\].

###### 

Pulmonary functions according to body mass index classification

                   Normal (s=60)        Obese (s=60)        *P*
  ---------------- -------------------- ------------------- -----------
  FVC (%)          92.4±16.2            84.6±19.1           0.018\*
  FEV~1~ (%)       91.7-19.6            79.2±21.6           0.001\*\*
  PEF (%)          68.7±19.9            61.7±22.6           0.075
  MEF~25-75~ (%)   81.8±31.3            58.4±22.5           0.003\*\*
  MEF~75~ (%)      73.6±22.6            61.5±24.5           0.006\*\*
  MEF~50~ (%)      82.6±31.9            57.8±23.0           0.000\*\*
  MEF~25~ (%)      79.6 (20.9-245.9)    56.2 (24.2-256.6)   0.001\*\*
  FEV~1~/FVC       103.6 (69.7-126.9)   99.3 (69.1-130.2)   0.016\*

\**P*\<0.05, \*\**P*\<0.01. Normally distributed data was presented as mean±SD, while nonnormally distributed data was presented as median (Q3-Q1). FEV~1~: Forced expiratory volume in 1 s, FVC: Forced vital capacity, PEF: Peak expiratory flow, MEF: Mid-expiratory flow, SD: Standard deviation

When the pulmonary function of the respondents was compared according to their WC classification, the FEV~1~, MEF~25--75~, MEF~75~, MEF~50~, MEF~25~, and FEV~1~/FVC values in the respondents with normal WC were found to be higher than in the respondents at risk and at high risk (*P* \< 0.05). Pulmonary function decreased with increasing WC \[[Table 3](#T3){ref-type="table"}\].

###### 

Pulmonary function according to waist circumference classification

                   Normal (s=50)        At risk + At high risk (s=70)   *P*
  ---------------- -------------------- ------------------------------- -----------
  FVC (%)          91.5±18.1            86.3±17.9                       0.125
  FEV~1~ (%)       93.8±22.7            79.5±18.1                       0.010\*
  PEF (%)          69.1±21.4            62.5±21.3                       0.094
  MEF~25-75~ (%)   84.5±31.6            59.8±23.2                       0.000\*\*
  MEF~75~ (%)      74.0±24.3            62.9±23.3                       0.014\*
  MEF~50~ (%)      85.0±31.5            59.6±24.7                       0.000\*\*
  MEF~25~ (%)      83.0 (23.1-245.9)    59.0 (20.9-256.6)               0.001\*\*
  FEV~1~/FVC       104.9 (69.7-126.9)   98.7 (69.1-130.2)               0.016\*

\**P*\<0.05, \*\**P*\<0.01. Normally distributed data was presented as mean±SD, while nonnormally distributed data were presented as median (Q3-Q1). FEV~1~: Forced expiratory volume in 1 s, FVC: Forced vital capacity, PEF: Peak expiratory flow, MEF: Mid-expiratory flow, SD: Standard deviation

When the pulmonary functions of the respondents were compared according to the WHR classification, the FEV~1~, MEF~25-75~, MEF~50,~ MEF~25~, and FEV~1~/FVC values in the respondents with normal WHR values were found to be higher than those recorded in the respondents who were at risk (*P* \< 0.05) \[[Table 4](#T4){ref-type="table"}\].

###### 

Pulmonary function according to waist-hip ratio classification

                   Normal (s=60)        At risk (s=60)      *P*
  ---------------- -------------------- ------------------- -----------
  FVC (%)          90.2±17.9            86.8±18.2           0.299
  FEV~1~ (%)       90.1±20.7            80.9±21.0           0.018\*
  PEF (%)          66.1±20.9            64.4±22.2           0.683
  MEF~25-75~ (%)   80.1±31.0            60.1±24.5           0.000\*\*
  MEF~75~ (%)      70.1±23.9            64.9±24.6           0.244
  MEF~50~ (%)      80.4±31.3            60.1±25.9           0.000\*\*
  MEF~25~ (%)      81.2 (23.1-245.9)    57.3 (20.9-256.6)   0.007\*\*
  FEV~1~/FVC       103.6 (69.7-129.8)   99.3 (69.1-130.2)   0.000\*\*

\**P*\<0.05, \*\**P*\<0.01. Normally distributed data was presented as mean±SD, while nonnormally distributed data were presented as median (Q3-Q1). FEV~1~: Forced expiratory volume in 1 s, FVC: Forced vital capacity, PEF: Peak expiratory flow, MEF: Mid-expiratory flow, SD: Standard deviation

[Figure 2](#F2){ref-type="fig"} presents the ACT scores of the respondents according to their WC, WHR, and BMI values. The asthma control scores decreased with increasing WC, and this decrease was more pronounced between the respondents with normal WC and the high-risk respondents (*P* \< 0.01). Similarly, the ACT scores of the respondents with normal WHR (20.2 ± 2.5) were significantly higher than the at-risk respondents (18.3 ± 3.8) (*P* \< 0.01). When the relationship between ACT score and BMI was analyzed, an increasing BMI was found to be inversely related to ACT scores which decreased significantly with an increasing severity of obesity (*P* \< 0.01).

![The asthma control test scores according to waist circumference classification (a) waist--hip ratio classification (b) and body mass index classification (c) ♦ Indicates differences between groups ─*P* \<0.05, ─ ─*P* \<0.01](LI-36-404-g002){#F2}

While the analysis of macro--micro nutrient intake did not reveal any difference in saturated fatty acid, omega 6, total fat, monounsaturated fatty acid, or polyunsaturated fatty acid intake, the energy (1710.4 ± 336.3; 1558.3 ± 326.2 kcal) and carbohydrate (187.9 ± 46.8; 165.3 ± 44.8 g) intakes were found to be higher in the obese group than in the normal weight group. Protein intake was lower in the obese group than in the normal weight group (48.9; 60.8 g) (*P* \< 0.05) \[[Table 5](#T5){ref-type="table"}\].

###### 

Mean energy and macronutrient uptake

                              Obese (s=60)        Normal (s=60)       *P*
  --------------------------- ------------------- ------------------- -----------
  Energy (kcal)               1710.4±336.3        1558.3±326.2        0.013\*
  Carbohydrate (g)            187.9±46.8          165.3±44.8          0.008\*\*
  Saturated fatty acids (g)   25.3±7.4            23.6±8.1            0.225
  Omega 6 (g)                 17.8±9.3            18.7±10.5           0.604
  Protein (g)                 48.9 (23.8-144.6)   60.8 (31.6-118.2)   0.003\*\*
  Fats (g)                    74.7 (31.0-154.3)   73.4 (172.0-34.3)   0.493
  MUFA (g)                    23.5 (9.3-64.9)     23.4 (11.4-60.6)    0.569
  PUFA (g)                    19.7 (3.3-58.3)     19.0 (4.5-56.9)     0.813
  Ω 3 (g)                     1.1 (0.25-10.9)     1.1 (0.51-24.1)     0.265

\**P*\<0.05 \*\**P*\<0.01. Normally distributed data was presented as mean±SD, while nonnormally distributed data were presented as median (Q3-Q1). MUFA: Monounsaturated fatty acid, PUFA: Polyunsaturated fatty acid, SD: Standard deviation

When the anthropometric measurements of the respondents and their ACT scores were compared, negative correlations were found between ACT scores and WHR (*r* = −0.262; *P* \< 0.05), WC (*r* = −0.356; *P* \< 0.01), and BMI (*r* = −0.353; *P* \< 0.01) measurements. When the ACT scores and macronutrients were analyzed, the ACT scores were found to be negatively correlated with total energy (*r* = −0.302; *P* \< 0.01) and carbohydrate intake (*r* = −0.238; *P* \< 0.01), while protein (*r* = 0.214; *P* \< 0.05) and omega 3 (*r* = 0.209; *P* \< 0.05) intake were positively correlated with ACT scores \[[Figure 3](#F3){ref-type="fig"}\].

![Correlations of asthma control test scores with macro--micro nutrient uptakes and anthropometric measurements. \**P* \< 0.05, \*\**P* \< 0.01. MUFA: Monounsaturated fatty acid; PUFA: Polyunsaturated fatty acid; SFA: Saturated fatty acid; WHR: Waist--hip ratio; WC: Waist circumference; BMI: Body mass index](LI-36-404-g003){#F3}

DISCUSSION {#sec1-4}
==========

Pulmonary functions decrease due to fatty thorax and the associated decrease in diaphragm motility in obese patients. The systemic and local inflammation caused by fat tissue further enhances these effects and complicates asthma control in obese respondents.\[[@ref22]\] In the present study, the FVC, FEV~1~, PEF, MEF~25--75~, MEF~75,~ MEF~50~, MEF~25~, and FVC/FEV~1~ values of obese respondents were found to be significantly lower than in the respondents with normal BMIs (*P* \< 0.05). In a cross-sectional study carried out by Leone *et al*. involving 121,965 patients who referred to their clinics between 1999 and 2006, a significant decrease was noted in pulmonary function as BMI values increased.\[[@ref23]\] In another study, Bruno *et al*.\[[@ref24]\] reported that FEV~1~, FVC, and FEV~1~/FVC values decreased as BMI increased, and people with normal BMIs recorded the highest pulmonary function values. In line with the above findings, Steier *et al*. found that the FEV~1~, FVC, and FEV~1~/FVC values of obese people were significantly lower than those recorded in people with normal BMI values (*P* \< 0.05).\[[@ref25]\]

The decrease in pulmonary function related to asthma also manifests through increasing abdominal obesity. Respiratory capacity decreases and sufferers become incapable of complete respiration, particularly in the presence of increased fat tissue in the WC and elevated WHR.\[[@ref26]\] Furthermore, respiratory maneuvers become shorter, more frequent, and limiting than in normal individuals.\[[@ref24]\] In a study by Baruah *et al*., the FEV~1~ and FVC values of the respondents classified as at risk and at high risk based on their WC were found to be lower than in the respondents with a normal WC (*P* \< 0.05).\[[@ref26]\] In a cross-sectional study involving 1674 participants carried out by Chen *et al*. investigating the relationship between WC and pulmonary function, increased WC measurements were found to be associated with decreased pulmonary function. Based on their results, a mean WC increase of 1 cm was found to cause a 13 ml decrease in FVC and an 11 ml decrease in FEV~1~.\[[@ref27]\] Similar to the abovementioned studies, a study investigating the relationship between body fat distribution and pulmonary function reported an inverse relationship between WC and WHR, and FEV~1~ and FVC values.\[[@ref28]\] In the present study, the FEV~1~, MEF~25--75~, MEF~75~, MEF~50~, MEF~25~, and FEV~1~/FVC values of those in the at risk and at high-risk groups based on their WC measurements were found to be significantly lower than in those with a normal WC (*P* \< 0.05). This finding is consistent with literature. Similar to WC, an increase in WHR has also been found to be inversely correlated with pulmonary functions (except for MEF~75~).

When the ACT scores of the respondents were analyzed based on their WC and WHR classification, those in that risk or high-risk groups were found to be lower than in the normal group (*P* \< 0.05). In a randomized controlled trial performed by Lv *et al*. involving 90 asthmatic patients, an increase in WC was found to decrease asthma control, which is consistent with the findings of the present study (*P* \< 0.05).\[[@ref29]\] Another study investigating the effects of adipose tissue on asthma control in adolescents showed that an increase in the amount of adipose tissue decreased asthma control (*P* \< 0.05).\[[@ref1]\] In another study, involving 38 obese asthmatic patients, Scott *et al*. found that decreasing WC improved asthma control (*P* \< 0.05).\[[@ref30]\]

Along with prolonged disease duration, an increase in the amount of medication used (particularly systemic corticosteroids) may result in increased appetite, and therefore, a higher food intake.\[[@ref31]\] Of the respondents in the present study, 30.8% reported increased body weight and 20.8% reported increased appetite after starting to use antiasthma medications. The number of respondents reporting increased body weight and appetite was higher in the obese group than in the normal weight group. The fact that those in the obese group in particular reported increased body weight and appetite after starting asthma medications can be attributed them reflecting their overeating behaviors to another cause. Obese people may circumvent the responsibility of their inability to control the eating instinct by attributing the problem to another cause.\[[@ref32]\]

Considering that people with asthma tend to live sedentary lifestyles due to their respiratory problems, they may be more prone to obesity. In addition to insufficient physical activity, the overconsumption of energy and carbohydrates further trigger tendencies to obesity and effect people with asthma in a vicious cycle.\[[@ref22]\] In the present study, the total energy and carbohydrate intakes of the obese respondents were found to be higher than those with normal body weight (*P* \< 0.05). Moreover, a negative correlation was noted between ACT scores and total energy and carbohydrate intake (*P* \< 0.01). Previous studies investigating this subject have also reported decreased asthma control with high levels of energy and carbohydrate intake and showed improvements in ACT scores with energy and carbohydrate-limiting diets.\[[@ref30][@ref33]\] Unlike energy and carbohydrate intake, protein intake was found to be lower in obese people than in those of normal weight and was positively correlated with ACT scores (*P* \< 0.05). An increase in protein intake is known to increase respiratory smooth muscle and contractile number and to allow stronger respiration.\[[@ref34]\] Similarly, in the study of Barros *et al*., the protein intake of those whose asthma was under control was found to be higher than in those with uncontrolled asthma.\[[@ref35]\]

Several diet hypothesis has been put forward over the last 15 years in relation to asthma, and changing dietary content has been stated as one of the leading environmental factors in the development of asthma.\[[@ref10]\] In particular, diets that are rich in omega 3 and antioxidant vitamins--minerals, such as the Mediterranean diet, are known to decrease symptoms of asthma.\[[@ref33]\] In the present study, a positive significant correlation was identified between omega 3 intake and ACT score (*P* \< 0.05), and there have been previous studies reporting that a high omega 3 intake alleviates asthma symptoms, while also providing further protection from the development of symptoms.\[[@ref31][@ref36]\] In contrast, ACT scores would appear to be unaffected by vitamin--mineral intake, which may be attributed to the fact that both the obese and normal weight groups consumed insufficient amounts of fruit and vegetables. Although high fruit and vegetable consumption is believed to decrease asthma symptoms, there have been previous studies reporting conflicting findings on this matter.\[[@ref37][@ref38]\]

This study has some limitations. First of all, the results of the study cannot be extrapolated to the entire population, as it study was conducted at a single center. In addition, due to limited research period, the study was conducted only during the spring months and may reflect results specific to this season. There was no bias in the subject selection, and all of those who were eligible for inclusion who referred to the clinics over a 2-month period were included in the study. In addition, there were a lot more women included in the study than men, although this difference in the prevalence of asthma between genders is a global fact. As a result of the effects of sex hormones after puberty, asthma is more commonly seen among women than men.\[[@ref39]\]

Despite all these limitations, the comparison of the characteristics of asthma with both anthropometric measurements and the uptake of nutrients has increased the strength of the study. By making a comparison of the characteristics of asthma according to the WC and WHR classification in addition to BMI has revealed not only the effect of total obesity but also the effects of abdominal obesity on asthma. Furthermore, the investigation of the relationship between the ACT score and macronutrients and vitamins--minerals has served to highlight the effects of nutritional habits on asthma control.

CONCLUSIONS {#sec1-5}
===========

The results of this study have shown that ACT scores and pulmonary functions decreased with increasing BMI, WC, and WHR values in adults with asthma. Data on the food intake of the respondents suggested a correlation between that some micro--macro nutrients and ACT scores. Considering that the prevalence of obesity has been increasing day by day and that today\'s nutritional habits are based mostly on processed foods rather than antioxidant-rich fruit and vegetables, the results of this study are consistent with each other. Based on the findings of this study, it would seem to be appropriate to refer obese asthmatic people to nutrition and diet outpatient clinics for correct diet recommendations, as decreased body weight will be effective in reducing the symptoms of asthma and in improving quality of life.
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